# Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

> **NCT00294775** · PHASE3 · UNKNOWN · sponsor: **Odense University Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Aortic Valve Stenosis
- Left Ventricular Hypertrophy
- Atrial Fibrillation

## Interventions

- **DRUG:** Candesartan

## Key facts

- **NCT ID:** NCT00294775
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00294775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00294775, "Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00294775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*